{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"acetazolamide-responsive-myotonia","columns":[{"gene":"","key":"population-6c9493c7b580b2d9f65f","label":"Acetazolamide-responsive myotonia","mondoId":"MONDO:0020483","onsetQualifier":null,"originColumnKey":"MONDO:0020483/ORPHA:99736","originalViews":[{"key":"MONDO:0020483/ORPHA:99736","label":"Acetazolamide-responsive myotonia","scopeLabel":"ORPHA:99736","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["05b5e5163cb4ed2b9bedc53690b61e8f815704143647966a28e3fbcc4ec7ac6c","2046a2e4f7fbc0c80be4537383ca8346eeacafb96ea21a43180060f9f5e576e9","20bd9b5c2e50401c3bdfefcc1f6bf50f9935a5508bb483fbe12bbe082a212c42","3929ce79f8220c815593278fc16f6062e1b307e8a4d9d4580fa54cf02ab6f2d0","6c359d89dddb1f570f17d1ee1ff6b00ce552fd589bdc41ca3d3e53f58a452449","85a9a465ff11d54f1f95f0a4e53b878c417bbc905ab0ef361b846b21d2bcec15","8b364ce1f70a24d8ae62a377b012a9d382fcc5ec9a0fddff9855fd77037c72ea","95718ba1226d451abb53bdcdbba268483370f740b20bc4a2a13dbcf258f4310f","98490cd6278780160da5b633b1f625ab68152e3f312d35814fa9a21a8c845115","d433b56d8bd48c15ef624771572fe87bcd61bd987b137a155abf0699c989c2bf","df1de1977c9a8c62c071b5fa43427767480691d140dbdb5eba4955090d51987f","e0fb1b4d3453de2b3b2415054a26cedbb3890c3abc9d24066da729d27d31e3ff"],"recordQualifiers":{},"scopeLabel":"ORPHA:99736","sourceIds":["ORPHA:99736"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6c9493c7b580b2d9f65f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0100749","HP:0002015","HP:0003457","HP:0001288","HP:0001276","HP:0000821","HP:0003394"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"orphanet":12}},"features":[{"hpoId":"HP:0100749","label":"Chest pain","primary":true},{"hpoId":"HP:0002015","label":"Dysphagia","primary":true},{"hpoId":"HP:0003457","label":"EMG abnormality","primary":true},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":true},{"hpoId":"HP:0001276","label":"Hypertonia","primary":true},{"hpoId":"HP:0000821","label":"Hypothyroidism","primary":true},{"hpoId":"HP:0003394","label":"Muscle spasm","primary":true},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0002486","label":"Myotonia","primary":false},{"hpoId":"HP:0000597","label":"Ophthalmoparesis","primary":false},{"hpoId":"HP:0000602","label":"Ophthalmoplegia","primary":false},{"hpoId":"HP:0003712","label":"Skeletal muscle hypertrophy","primary":false}],"ledeHtml":"Acetazolamide-responsive myotonia is a form of potassium-aggravated myotonia (PAM) which shows dramatic improvement with the use of acetazolamide (ACZ).","mondoId":"MONDO:0020483","node":{"canonicalSlug":"acetazolamide-responsive-myotonia","comparisons":[{"documentSha256":"858f78194e992cd8607303c5c69047a73e61a184af3d2b324007f96e52e880a4","key":"legacy-potassium-aggravated-myotonia","kind":"legacy","label":"potassium-aggravated myotonia","memberIds":["MONDO:0018959","MONDO:0020481","MONDO:0020482","MONDO:0020483"],"mondoId":"MONDO:0018959","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/potassium-aggravated-myotonia.858f78194e992cd8607303c5c69047a73e61a184af3d2b324007f96e52e880a4.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"acetazolamide-responsive myotonia","paragraphs":["Acetazolamide-responsive myotonia is a form of potassium-aggravated myotonia (PAM) which shows dramatic improvement with the use of acetazolamide (ACZ)."],"scope":"exact","source":"MONDO","upstream":"Orphanet:99736","url":"https://monarchinitiative.org/MONDO:0020483"},"ownColumnKeys":["population-6c9493c7b580b2d9f65f"],"publication":"published","relationships":[{"kind":"parent","label":"potassium-aggravated myotonia","mondoId":"MONDO:0018959","slug":"potassium-aggravated-myotonia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/16906"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"05b5e5163cb4ed2b9bedc53690b61e8f815704143647966a28e3fbcc4ec7ac6c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2046a2e4f7fbc0c80be4537383ca8346eeacafb96ea21a43180060f9f5e576e9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"20bd9b5c2e50401c3bdfefcc1f6bf50f9935a5508bb483fbe12bbe082a212c42","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100749","is_excluded":false,"label":"Chest pain","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3929ce79f8220c815593278fc16f6062e1b307e8a4d9d4580fa54cf02ab6f2d0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003457","is_excluded":false,"label":"EMG abnormality","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c359d89dddb1f570f17d1ee1ff6b00ce552fd589bdc41ca3d3e53f58a452449","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"85a9a465ff11d54f1f95f0a4e53b878c417bbc905ab0ef361b846b21d2bcec15","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000602","is_excluded":false,"label":"Ophthalmoplegia","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8b364ce1f70a24d8ae62a377b012a9d382fcc5ec9a0fddff9855fd77037c72ea","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003394","is_excluded":false,"label":"Muscle spasm","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"95718ba1226d451abb53bdcdbba268483370f740b20bc4a2a13dbcf258f4310f","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000597","is_excluded":false,"label":"Ophthalmoparesis","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98490cd6278780160da5b633b1f625ab68152e3f312d35814fa9a21a8c845115","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000821","is_excluded":false,"label":"Hypothyroidism","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d433b56d8bd48c15ef624771572fe87bcd61bd987b137a155abf0699c989c2bf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003712","is_excluded":false,"label":"Skeletal muscle hypertrophy","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"df1de1977c9a8c62c071b5fa43427767480691d140dbdb5eba4955090d51987f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001276","is_excluded":false,"label":"Hypertonia","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e0fb1b4d3453de2b3b2415054a26cedbb3890c3abc9d24066da729d27d31e3ff","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:99736","disease_name":"Acetazolamide-responsive myotonia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002486","is_excluded":false,"label":"Myotonia","onset_id":null,"reference":"ORPHA:99736","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0020483\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:99736</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Acetazolamide-responsive myotonia is a form of potassium-aggravated myotonia (PAM) which shows dramatic improvement with the use of acetazolamide (ACZ).</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0020483\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"acetazolamide-responsive-myotonia","sourceDocuments":[{"name":"MONDO: acetazolamide-responsive myotonia","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0020483"}],"sourceNote":"","synonyms":["Acetazolamide-responsive congenital myotonia","ACZ-responsive congenital myotonia","ACZ-responsive myotonia","myotonia-painful contractions syndrome","painful congenital myotonia","painful myotonia"],"takeawayHtml":"","title":"acetazolamide-responsive myotonia"},"schemaVersion":1}
